Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Systemic Anti-infective Drugs Market by Type
 5.1 Systemic Anti-infective Drugs Market Overview Snapshot and Growth Engine
 5.2 Systemic Anti-infective Drugs Market Overview
 5.3 Antibacterial Drugs
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2030F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Antibacterial Drugs: Geographic Segmentation
 5.4 Antifungals
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2030F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Antifungals: Geographic Segmentation
 5.5 Antiviral and Antiparasitic Drugs
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2030F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Antiviral and Antiparasitic Drugs: Geographic Segmentation

Chapter 6: Systemic Anti-infective Drugs Market by Application
 6.1 Systemic Anti-infective Drugs Market Overview Snapshot and Growth Engine
 6.2 Systemic Anti-infective Drugs Market Overview
 6.3 Hospital
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2030F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospital: Geographic Segmentation
 6.4 Clinic
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2030F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Clinic: Geographic Segmentation
 6.5 Other
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2030F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Other: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Systemic Anti-infective Drugs Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Systemic Anti-infective Drugs Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Systemic Anti-infective Drugs Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 PFIZER
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 SUMITOMO DAINIPPON PHARMA
 7.4 MSD
 7.5 BAYER
 7.6 BRISTOL-MYERS SQUIBB
 7.7 DECHRA
 7.8 ALANDALOUS
 7.9 ZHENGDA TIANQING
 7.10 LUOXIN PHARMACEUTICAL
 7.11 SOUTHWEST PHARMACEUTICAL
 7.12 GUANGZHOU BAIYUN MOUNTAIN
 7.13 HARBIN PHARMACEUTICAL GROUP
 7.14 CSPC
 7.15 NORTH CHINA PHARMACEUTICAL
 7.16 SINOPHARM GROUP

Chapter 8: Global Systemic Anti-infective Drugs Market Analysis, Insights and Forecast, 2016-2030
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Antibacterial Drugs
  8.2.2 Antifungals
  8.2.3 Antiviral and Antiparasitic Drugs
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Hospital
  8.3.2 Clinic
  8.3.3 Other

Chapter 9: North America Systemic Anti-infective Drugs Market Analysis, Insights and Forecast, 2016-2030
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Antibacterial Drugs
  9.4.2 Antifungals
  9.4.3 Antiviral and Antiparasitic Drugs
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Hospital
  9.5.2 Clinic
  9.5.3 Other
 9.6 Historic and Forecast Market Size by Country
  9.6.1 US
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Eastern Europe Systemic Anti-infective Drugs Market Analysis, Insights and Forecast, 2016-2030
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Antibacterial Drugs
  10.4.2 Antifungals
  10.4.3 Antiviral and Antiparasitic Drugs
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Hospital
  10.5.2 Clinic
  10.5.3 Other
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Bulgaria
  10.6.2 The Czech Republic
  10.6.3 Hungary
  10.6.4 Poland
  10.6.5 Romania
  10.6.6 Rest of Eastern Europe

Chapter 11: Western Europe Systemic Anti-infective Drugs Market Analysis, Insights and Forecast, 2016-2030
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Antibacterial Drugs
  11.4.2 Antifungals
  11.4.3 Antiviral and Antiparasitic Drugs
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Hospital
  11.5.2 Clinic
  11.5.3 Other
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Germany
  11.6.2 UK
  11.6.3 France
  11.6.4 Netherlands
  11.6.5 Italy
  11.6.6 Russia
  11.6.7 Spain
  11.6.8 Rest of Western Europe

Chapter 12: Asia Pacific Systemic Anti-infective Drugs Market Analysis, Insights and Forecast, 2016-2030
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Antibacterial Drugs
  12.4.2 Antifungals
  12.4.3 Antiviral and Antiparasitic Drugs
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Hospital
  12.5.2 Clinic
  12.5.3 Other
 12.6 Historic and Forecast Market Size by Country
  12.6.1 China
  12.6.2 India
  12.6.3 Japan
  12.6.4 South Korea
  12.6.5 Malaysia
  12.6.6 Thailand
  12.6.7 Vietnam
  12.6.8 The Philippines
  12.6.9 Australia
  12.6.10 New Zealand
  12.6.11 Rest of APAC

Chapter 13: Middle East & Africa Systemic Anti-infective Drugs Market Analysis, Insights and Forecast, 2016-2030
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Antibacterial Drugs
  13.4.2 Antifungals
  13.4.3 Antiviral and Antiparasitic Drugs
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Hospital
  13.5.2 Clinic
  13.5.3 Other
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Turkey
  13.6.2 Bahrain
  13.6.3 Kuwait
  13.6.4 Saudi Arabia
  13.6.5 Qatar
  13.6.6 UAE
  13.6.7 Israel
  13.6.8 South Africa

Chapter 14: South America Systemic Anti-infective Drugs Market Analysis, Insights and Forecast, 2016-2030
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Antibacterial Drugs
  14.4.2 Antifungals
  14.4.3 Antiviral and Antiparasitic Drugs
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Hospital
  14.5.2 Clinic
  14.5.3 Other
 14.6 Historic and Forecast Market Size by Country
  14.6.1 Brazil
  14.6.2 Argentina
  14.6.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

Systemic Anti-infective Drugs Scope:

Report Data	Systemic Anti-infective Drugs Market
Systemic Anti-infective Drugs Market Size in 2022	USD 344.00 million
Systemic Anti-infective Drugs CAGR 2023 - 2030	5.30%
Systemic Anti-infective Drugs Base Year	2022
Systemic Anti-infective Drugs Forecast Data	2023 - 2030
Segments Covered	By Type, By Application, And by Regions
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Pfizer, Sumitomo Dainippon Pharma, MSD, Bayer, Bristol-Myers Squibb, Dechra, Alandalous, Zhengda Tianqing, Luoxin Pharmaceutical, Southwest Pharmaceutical, Guangzhou Baiyun Mountain, Harbin Pharmaceutical Group, CSPC, North China Pharmaceutical, Sinopharm Group.
Key Segments	By Type Antibacterial Drugs Antifungals Antiviral and Antiparasitic Drugs By Applications Hospital Clinic Other